COVFIS-HOME: COVID-19 Pilot Study of Fisetin to Alleviate Dysfunction and Decrease Complications

NCT04771611 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Covid19
Coronavirus Infection

Interventions

DRUG: Fisetin
DRUG: Placebo

Sponsor

James L. Kirkland, MD, PhD